Literature DB >> 7646421

ATP-sensitive potassium channels and myocardial preconditioning.

G J Gross1.   

Abstract

The ATP-sensitive potassium channel (KATP) has been shown to serve an endogenous cardioprotective role in a number of experimental models of myocardial stunning and infarction. More importantly, a majority of evidence has also been obtained which suggests that the KATP channel may be intimately involved in both triggering and maintaining the cardioprotection afforded by the phenomenon of ischemic preconditioning particularly in large animal models such as dogs and pigs. Although the evidence for an involvement of KATP in ischemic pre-conditioning is equivocal in smaller animal species such as rabbits and rats, activation of this channel by KATP channel openers produces cardioprotection in all species studied. Whether this channel is an important mediator of ischemic preconditioning in all animal species including man and the mechanism by which this cardioprotective effect is obtained await further experimental studies. Nevertheless, the use of selective potassium channel openers to mimic preconditioning in selected clinical settings may be a desirable future therapeutic goal.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7646421     DOI: 10.1007/bf00789438

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  19 in total

Review 1.  KATP channels in ischaemic preconditioning.

Authors:  J R Parratt; K A Kane
Journal:  Cardiovasc Res       Date:  1994-06       Impact factor: 10.787

2.  Acetylcholine mimics ischemic preconditioning via a glibenclamide-sensitive mechanism in dogs.

Authors:  Z Yao; G J Gross
Journal:  Am J Physiol       Date:  1993-06

3.  Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide.

Authors:  C F Toombs; T L Moore; R J Shebuski
Journal:  Cardiovasc Res       Date:  1993-04       Impact factor: 10.787

4.  Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker.

Authors:  F Tomai; F Crea; A Gaspardone; F Versaci; R De Paulis; A Penta de Peppo; L Chiariello; P A Gioffrè
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

5.  Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine A1-receptors.

Authors:  G J Grover; P G Sleph; S Dzwonczyk
Journal:  Circulation       Date:  1992-10       Impact factor: 29.690

6.  Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts.

Authors:  J D Thornton; C S Thornton; D L Sterling; J M Downey
Journal:  Circ Res       Date:  1993-01       Impact factor: 17.367

7.  Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs.

Authors:  G J Gross; J A Auchampach
Journal:  Circ Res       Date:  1992-02       Impact factor: 17.367

8.  Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog.

Authors:  T Mizumura; K Nithipatikom; G J Gross
Journal:  Cardiovasc Res       Date:  1995-04       Impact factor: 10.787

9.  Ischemic preconditioning protects against infarction in rat heart.

Authors:  Y Liu; J M Downey
Journal:  Am J Physiol       Date:  1992-10

10.  Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium.

Authors:  Y Liu; K Ytrehus; J M Downey
Journal:  J Mol Cell Cardiol       Date:  1994-05       Impact factor: 5.000

View more
  22 in total

1.  Constitutive activation of A(3) adenosine receptors by site-directed mutagenesis.

Authors:  A Chen; Z G Gao; D Barak; B T Liang; K A Jacobson
Journal:  Biochem Biophys Res Commun       Date:  2001-06-15       Impact factor: 3.575

2.  Effects of potassium channel opener KRN4884 on human conduit arteries used as coronary bypass grafts.

Authors:  Z Ren; S Floten; A Furnary; M Liu; H Gately; J Swanson; A Ahmad; A P Yim; G W He
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

3.  Randomized controlled trial of laparoscopic gastric ischemic conditioning prior to minimally invasive esophagectomy, the LOGIC trial.

Authors:  Darmarajah Veeramootoo; Angela C Shore; Shahjehan A Wajed
Journal:  Surg Endosc       Date:  2012-02-01       Impact factor: 4.584

4.  ATP-sensitive K+ channel openers prevent Ca2+ overload in rat cardiac mitochondria.

Authors:  E L Holmuhamedov; L Wang; A Terzic
Journal:  J Physiol       Date:  1999-09-01       Impact factor: 5.182

Review 5.  K+ channel opening: a new drug principle in cardiovascular medicine.

Authors:  J E Nielsen-Kudsk; S Boesgaard; J Aldershvile
Journal:  Heart       Date:  1996-08       Impact factor: 5.994

6.  Protein kinase C-dependent activation of KATP channel enhances adenosine-induced cardioprotection.

Authors:  B T Liang
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

Review 7.  Limitation of infarct size by myocardial ischemic preconditioning.

Authors:  D M Van Winkle
Journal:  Basic Res Cardiol       Date:  1996 Jan-Feb       Impact factor: 17.165

8.  Distinct cardioprotective effects of adenosine mediated by differential coupling of receptor subtypes to phospholipases C and D.

Authors:  M Parsons; L Young; J E Lee; K A Jacobson; B T Liang
Journal:  FASEB J       Date:  2000-07       Impact factor: 5.191

9.  Cardiac myocytes rendered ischemia resistant by expressing the human adenosine A1 or A3 receptor.

Authors:  C Dougherty; J Barucha; P R Schofield; K A Jacobson; B T Liang
Journal:  FASEB J       Date:  1998-12       Impact factor: 5.191

10.  A physiological role of the adenosine A3 receptor: sustained cardioprotection.

Authors:  B T Liang; K A Jacobson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.